Our results regarding MetS are interesting in that the significant association between MetS and recurrence in ER/PR-negative tumors disappeared after adjustment for HOMA-IR and adiponectin in model 2, suggesting that insulin resistance and adipokines mediate the effects of MetS. The gene discussed is ADIPOQ; the disease is metabolic syndrome.